Assessment of the efficacy of erenumab during the open-label treatment phase (13-24 Weeks) of the LIBERTY studyU. Reuter,P. J. Goadsby, M. Lanteri-Minet,P. Hours-Zesiger, C. Fernandes,M. Ferrari,J. KlattEUROPEAN JOURNAL OF NEUROLOGY(2019)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要